Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization
- PMID: 34034135
- DOI: 10.1016/j.bioorg.2021.104988
Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization
Abstract
Here, we report the structural optimization of a hit natural compound, 2-ME2 (2-methoxyestradiol), which exhibited inhibitory activity but low potency on tubulin polymerization, anti- angiogenesis, MCF-7 proliferation and metastasis in vitro and in vivo. A novel series of 3,17-modified and 17-modified analogs of 2-ME2 were synthesized and investigated for their antiproliferative activity against MCF-7 and another five different human cancer cell lines leading to the discovery of 9i. 9i bind to tubulin colchicine site tightly, inhibited tubulin polymerization and disrupted cellular microtubule networks. Cellular mechanism studies revealed that 9i could induce G2/M phase arrest by down-regulated expression of p-Cdc2, P21 and cell apoptosis by regulating apoptosis-related proteins (Parp, Caspase families) in a dose-dependent manner. Importantly, 9i significantly inhibited HUVEC tube formation, proliferation, migration and invasion. The inhibitory effect against angiogenesis in vivo was confirmed by zebrafish xenograft. Furthermore, 9i could effectively inhibit the proliferation and metastasis of MCF-7 cells in vitro and in zebrafish xenograft. The satisfactory physicochemical property and metabolic stability of 9i further indicated that it can act as a promising and potent anti-angiogenesis, inhibiting proliferation and metastasis of breast cancer agent via targeting tubulin colchicine binding site.
Keywords: Angiogenesis; Breast cancer; Metastasis; Tubulin.
Copyright © 2021. Published by Elsevier Inc.
Similar articles
-
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.J Enzyme Inhib Med Chem. 2022 Dec;37(1):339-354. doi: 10.1080/14756366.2021.2014831. J Enzyme Inhib Med Chem. 2022. PMID: 34979843 Free PMC article.
-
Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.Eur J Med Chem. 2021 Dec 5;225:113790. doi: 10.1016/j.ejmech.2021.113790. Epub 2021 Aug 19. Eur J Med Chem. 2021. PMID: 34454126
-
Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.J Enzyme Inhib Med Chem. 2022 Dec;37(1):652-665. doi: 10.1080/14756366.2022.2032688. J Enzyme Inhib Med Chem. 2022. PMID: 35109719 Free PMC article.
-
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772. J Enzyme Inhib Med Chem. 2022. PMID: 34894980 Free PMC article. Review.
-
A review on Millepachine and its derivatives as potential multitarget anticancer agents.Biochem Biophys Res Commun. 2023 Nov 12;681:249-270. doi: 10.1016/j.bbrc.2023.09.044. Epub 2023 Sep 19. Biochem Biophys Res Commun. 2023. PMID: 37793311 Review.
Cited by
-
Alkaloids as Additional Weapons in the Fight against Breast Cancer: A Review.Curr Med Chem. 2024;31(32):5113-5148. doi: 10.2174/0929867331666230911162527. Curr Med Chem. 2024. PMID: 37702171 Review.
-
Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.J Enzyme Inhib Med Chem. 2022 Dec;37(1):339-354. doi: 10.1080/14756366.2021.2014831. J Enzyme Inhib Med Chem. 2022. PMID: 34979843 Free PMC article.
-
Angiogenesis, Anti-Tumor, and Anti-Metastatic Activity of Novel α-Substituted Hetero-Aromatic Chalcone Hybrids as Inhibitors of Microtubule Polymerization.Front Chem. 2021 Nov 19;9:766201. doi: 10.3389/fchem.2021.766201. eCollection 2021. Front Chem. 2021. PMID: 34900935 Free PMC article.
-
Zebrafish live imaging: a strong weapon in anticancer drug discovery and development.Clin Transl Oncol. 2024 Aug;26(8):1807-1835. doi: 10.1007/s12094-024-03406-7. Epub 2024 Mar 21. Clin Transl Oncol. 2024. PMID: 38514602 Review.
-
Isoxazole-Based Compounds Targeting the Taxane-Binding Site of Tubulin.Arch Pharm (Weinheim). 2025 Jul;358(7):e70031. doi: 10.1002/ardp.70031. Arch Pharm (Weinheim). 2025. PMID: 40702793 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous